Bruker Co. (NASDAQ:BRKR) Holdings Decreased by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. reduced its stake in shares of Bruker Co. (NASDAQ:BRKR) by 7.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,241 shares of the medical research company’s stock after selling 588 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Bruker were worth $463,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of BRKR. First Horizon Advisors Inc. raised its stake in shares of Bruker by 120.4% during the second quarter. First Horizon Advisors Inc. now owns 399 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 218 shares in the last quarter. Rise Advisors LLC bought a new stake in Bruker in the first quarter worth about $27,000. Neo Ivy Capital Management bought a new stake in Bruker in the fourth quarter worth about $30,000. GAMMA Investing LLC bought a new stake in Bruker in the fourth quarter worth about $33,000. Finally, Covestor Ltd raised its position in Bruker by 139.1% in the first quarter. Covestor Ltd now owns 361 shares of the medical research company’s stock worth $34,000 after acquiring an additional 210 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

BRKR has been the topic of several research reports. Citigroup dropped their price target on shares of Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, July 10th. The Goldman Sachs Group dropped their price target on shares of Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research report on Tuesday, July 9th. Stifel Nicolaus dropped their price target on shares of Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a research report on Monday, May 20th. Wells Fargo & Company began coverage on Bruker in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $78.00 price target on the stock. Finally, Jefferies Financial Group began coverage on Bruker in a research note on Monday, June 3rd. They issued a “buy” rating and a $85.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $81.40.

Bruker Trading Down 0.5 %

NASDAQ:BRKR opened at $67.19 on Tuesday. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.65 and a quick ratio of 0.75. Bruker Co. has a fifty-two week low of $53.79 and a fifty-two week high of $94.86. The stock’s 50-day moving average is $63.91 and its two-hundred day moving average is $74.61. The stock has a market cap of $10.17 billion, a PE ratio of 24.43, a price-to-earnings-growth ratio of 2.43 and a beta of 1.20.

Bruker (NASDAQ:BRKR) last released its earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, meeting the consensus estimate of $0.52. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The company had revenue of $800.70 million for the quarter, compared to analysts’ expectations of $799.44 million. During the same quarter in the previous year, the business posted $0.50 EPS. The business’s revenue for the quarter was up 17.4% on a year-over-year basis. As a group, equities research analysts forecast that Bruker Co. will post 2.61 earnings per share for the current fiscal year.

Bruker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 16th. Shareholders of record on Monday, September 2nd will be paid a dividend of $0.05 per share. The ex-dividend date is Friday, August 30th. This represents a $0.20 annualized dividend and a yield of 0.30%. Bruker’s dividend payout ratio (DPR) is presently 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.